Prevalence and Risk Factors of Post-Tuberculosis Lung Disease in an Urban Tertiary Care Center
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.191 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Bhogilal Vitthaldas Patel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Post-tuberculosis lung disease (PTLD) is an increasingly recognized clinical entity characterized by persistent structural and functional pulmonary abnormalities following the completion of successful antitubercular therapy. Despite the enormous global burden of tuberculosis (TB), the long-term pulmonary sequelae affecting TB survivors remain inadequately studied, particularly in high-burden settings. This study aimed to determine the prevalence of PTLD and identify its associated risk factors among patients who completed antitubercular treatment at an urban tertiary care center.
Methods
This cross-sectional observational study was conducted, enrolling 320 patients who had successfully completed antitubercular therapy within the preceding 6 to 36 months. All participants underwent detailed clinical evaluation, spirometric pulmonary function testing, high-resolution computed tomography (HRCT) of the chest, the St. George's Respiratory Questionnaire (SGRQ), and the six-minute walk test (6MWT). PTLD was defined as the presence of persistent respiratory symptoms with corresponding radiological abnormalities and/or spirometric impairment following bacteriologically confirmed TB cure. Logistic regression analysis was employed to identify independent risk factors.
Results
PTLD was identified in 198 of 320 patients (61.9%). The most prevalent HRCT findings were bronchiectasis (48.5%), fibrotic bands (42.4%), and cavitary lesions (28.3%). Spirometric abnormalities were detected in 54.1% of PTLD patients, with obstructive pattern predominating (33.8%). Mean FEV1 % predicted was significantly lower in the PTLD group (62.4 ± 16.8%) compared with the non-PTLD group (86.3 ± 12.5%, p < 0.001). Independent risk factors for PTLD included smoking history (OR 3.24; 95% CI: 1.86–5.64; p < 0.001), delayed treatment initiation exceeding 60 days (OR 2.78; 95% CI: 1.54–5.02; p = 0.001), cavitary disease on initial radiograph (OR 2.91; 95% CI: 1.62–5.23; p < 0.001), retreatment TB (OR 2.46; 95% CI: 1.284.72; p = 0.007), and diabetes mellitus (OR 1.94; 95% CI: 1.12–3.36; p = 0.018).
Conclusion
PTLD affects a substantial majority of TB survivors and is associated with significant pulmonary functional impairment. Smoking history, delayed treatment initiation, initial cavitary disease, retreatment TB, and diabetes mellitus represent modifiable and identifiable risk factors that should guide targeted post-treatment surveillance and rehabilitation strategies.
Zitieren
APA
Patel, B. V., Patel, P. H., & Jansari, K. R. (2026). Prevalence and Risk Factors of Post-Tuberculosis Lung Disease in an Urban Tertiary Care Center. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.191
Vancouver
Patel BV, Patel PH, Jansari KR. Prevalence and Risk Factors of Post-Tuberculosis Lung Disease in an Urban Tertiary Care Center. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.191
BibTeX
@article{Patel2026,
author = {Patel, Bhogilal Vitthaldas and Patel, Parth H. and Jansari, Ketankumar R.},
title = {Prevalence and Risk Factors of Post-Tuberculosis Lung Disease in an Urban Tertiary Care Center},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.191}
}
EUVIMED